It has also been shown by Ladomersky et al. [37] that IDO expression seems to be increased in brain samples of “normal” brain from older patients, which further could add to the hypothesis that immune suppression is increased in these population and possibly part of the explanation to the fact that age is such an important prognostic factor in patients with glioblastoma. The gene discussed is IDO1; the disease is glioblastoma.